Завершено
Фаза II
Россия
Ibodutant; Ibodutant; Ibodutant; Placebo · Menarini Group
Double-blind, Randomised, Placebo-controlled, Parallel Group Study to Evaluate the Effect of a 4-week Treatment With Oral Doses of Ibodutant (Code: MEN15596) in Irritable Bowel Syndrome (IBS).